Who is sponsoring NCT02793830?

NCT02793830 is sponsored by Duke University.

What drugs are being tested in NCT02793830?

Interventions in NCT02793830: Daily reminders of taking medications, Educational materials.

What condition does NCT02793830 study?

NCT02793830 studies Medication Adherence.

Is NCT02793830 still recruiting?

NCT02793830 is currently completed. Last updated 30 January 2017.

Last reviewed 2017-01-30 · How we verify

NCT02793830

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Mobile Phone Based Medication Reminder Program

Completed NA Last updated 30 January 2017

What this trial tests

NA trial testing Daily reminders of taking medications in Medication Adherence in 49 participants. Completed in 12 November 2016.

Timeline

11 July 2016

Primary endpoint
19 September 2016

12 November 2016

Quick facts

Lead sponsor	Duke University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	49
Start date	11 July 2016
Primary completion	19 September 2016
Estimated completion	12 November 2016

Drugs / interventions tested

Daily reminders of taking medications
Educational materials

Conditions studied

Medication Adherence — all drugs for Medication Adherence →

Sponsor

Duke University

Who can join

18 and older, any sex, with Medication Adherence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the feasibility and acceptability of using mobile applications to improve medication adherence. Participants in the experimental group will receive educational materials and daily reminders through mobile applications. While, participants in the control group will receive only educational materials. After the intervention, interviews will be conducted among participants through phone calls.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

An mHealth Intervention to Improve Medication Adherence and Health Outcomes Among Patients With Coronary Heart Disease: Randomized Controlled Trial.
Ni Z, Wu B, Yang Q, Yan LL, et al · · 2022 · cited 41× · PMID 35262490 · DOI 10.2196/27202

Verify or expand the search:

Other recruiting trials for Medication Adherence

Currently open trials in the same condition.

NCT07420634 — Multilevel Ecological and COM-B Determinants of Medication Adherence in Adults With Diabetes · recruiting
NCT06876233 — Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication · NA · recruiting
NCT05624931 — Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa · NA · recruiting
NCT06949774 — INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND) · NA · recruiting
NCT06569290 — Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Sci · NA · active not recruiting

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02793830 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 30 January 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02793830.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing